Debt-to-equity of Disc Medicine, Inc. from 30 Jun 2021 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Disc Medicine, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2021 to 31 Dec 2025.
  • Disc Medicine, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 8.6%, a 28% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Disc Medicine, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 8.6% +1.9% +28% 31 Dec 2025
Q3 2025 9.2% +3.8% +72% 30 Sep 2025
Q2 2025 8.2% +3.2% +62% 30 Jun 2025
Q1 2025 7.3% +2.4% +49% 31 Mar 2025
Q4 2024 6.8% +1.9% +38% 31 Dec 2024
Q3 2024 5.3% -0.37% -6.4% 30 Sep 2024
Q2 2024 5.1% -2.1% -29% 30 Jun 2024
Q1 2024 4.9% -14% -74% 31 Mar 2024
Q4 2023 4.9% +61% 31 Dec 2023
Q3 2023 5.7% +17% 30 Sep 2023
Q2 2023 7.2% +68% 30 Jun 2023
Q1 2023 19% -17% -47% 31 Mar 2023
Q4 2022 -56% -72% -466% 31 Dec 2022
Q3 2022 -11% -29% -163% 30 Sep 2022
Q2 2022 -61% -84% -361% 30 Jun 2022
Q1 2022 35% 31 Mar 2022
Q4 2021 15% 31 Dec 2021
Q3 2021 18% 30 Sep 2021
Q2 2021 23% 30 Jun 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.